05Oct 2022
Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial

Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial

The possibility of combination therapy with atomoxetine (ATO) and oxybutynin (OXY) has been suggested for obstructive sleep apnoea (OSA). Overall, ATO–OXY therapy does not reduce AHI in Japanese OSA patients, although AHI was decreased in some patients. Future studies for identifying treatment response group characteristics are warranted.

  • #pulmonology

Like

Save

Share